General MedicationsINTRAVENOUSStandard
CLEVIPREX
CLEVIDIPINE
Standard Dose
50MG/100ML (0.5MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CLEVIPREX is listed in Drugs@FDA under application 022156 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CLEVIDIPINE Form and strength EMULSION;INTRAVENOUS - 50MG/100ML (0.5MG/ML) Sponsor CHIESI Submission history Latest submission status date: 2021-04-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLEVIPREX is listed in Drugs@FDA under application 022156 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLEVIDIPINE Form and strength EMULSION;INTRAVENOUS - 50MG/100ML (0.5MG/ML) Sponsor CHIESI Submission history Latest submission status date: 2021-04-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.